Literature DB >> 16807835

Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide.

Hervé Richet, Pierre Edouard Fournier.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16807835     DOI： 10.1086/505900

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  17 in total

1.  The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor.

Authors:  Thomas A Russo; Nicole R Luke; Janet M Beanan; Ruth Olson; Shauna L Sauberan; Ulrike MacDonald; L Wayne Schultz; Timothy C Umland; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Effect of a novel podophage AB7-IBB2 on Acinetobacter baumannii biofilm.

Authors:  Nikhil D Thawal; Ajinkya B Yele; Praveen K Sahu; Balu A Chopade
Journal:  Curr Microbiol       Date:  2012-04-26       Impact factor: 2.188

3.  Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii.

Authors:  Leticia V Bentancor; Ana Camacho-Peiro; Cagla Bozkurt-Guzel; Gerald B Pier; Tomás Maira-Litrán
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

4.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

5.  Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.

Authors:  Lona Mody; Kristen E Gibson; Amanda Horcher; Katherine Prenovost; Sara E McNamara; Betsy Foxman; Keith S Kaye; Suzanne Bradley
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-15       Impact factor: 3.254

6.  Economic value of Acinetobacter baumannii screening in the intensive care unit.

Authors:  B Y Lee; S M McGlone; Y Doi; R R Bailey; L H Harrison
Journal:  Clin Microbiol Infect       Date:  2011-04-04       Impact factor: 8.067

7.  Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis.

Authors:  Nicole R Luke; Shauna L Sauberan; Thomas A Russo; Janet M Beanan; Ruth Olson; Thomas W Loehfelm; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Anthony A Campagnari
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

8.  Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.

Authors:  Kristine M Hujer; Andrea M Hujer; Edward A Hulten; Saralee Bajaksouzian; Jennifer M Adams; Curtis J Donskey; David J Ecker; Christian Massire; Mark W Eshoo; Rangarajan Sampath; Jodi M Thomson; Philip N Rather; David W Craft; Joel T Fishbain; Allesa J Ewell; Michael R Jacobs; David L Paterson; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2006-09-25       Impact factor: 5.191

9.  Occupational transmission of Acinetobacter baumannii from a United States serviceman wounded in Iraq to a health care worker.

Authors:  Timothy J Whitman; Sonia S Qasba; Joseph G Timpone; Britta S Babel; Matthew R Kasper; Judith F English; John W Sanders; Kristine M Hujer; Andrea M Hujer; Andrea Endimiani; Mark W Eshoo; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Nicole R Luke; Steven R Gill; Anthony A Campagnari
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.